Filing Flows › Outset Medical (OM) › Q2 2026
Outset Medical (OM) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Outset Medical (OM) reported revenue of $31.6M for the second quarter 2026 (Q2 2026), +0.7% from a year earlier and +14% from the quarter before. Operating margin was -49.6%, net loss $18.0M (56.8% of revenue).
Outset Medical, Q2 2026: revenue $31.6M (+0.7% year over year), operating margin -49.6%, net loss $18.0M, operating cash flow −$9.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.6M | +14% | +0.7% |
| Operating profit | −$15.7M | — | — |
| Net earnings | −$18.0M | — | — |
| Operating cash flow | −$9.6M | — | — |
What changed
Revenue was $31.6M in Q2 2026, up 1% year over year and up 14% from the previous quarter. Consumables Product was the largest line at 39% of revenue. Service and Other Revenue added $1.4M year over year (up 17%), 644% of the total change. Consumables Product declined 12%.
Gross margin was 42.0%, up 4.2 points from Q2 2025. Operating costs exceeded revenue by $15.7M, an operating margin of -49.6%. Operating expenses grew 1% against revenue growth of 1%. The fastest-growing cost line was General & admin (+24%). The quarter ended with a net loss of $18.0M, narrower than the previous quarter's $19.0M loss.
Operating cash flow was −$9.6M. Non-cash charges added back $627K of depreciation and amortization and $2.7M of share-based compensation. Working capital and other items added $5.0M. Capital expenditures of $111K exceeded it, leaving free cash flow of −$9.7M.
Questions
What was Outset Medical's revenue in the second quarter 2026?
Outset Medical (OM) reported revenue of $31.6M for the second quarter 2026 (Q2 2026), +0.7% from a year earlier and +14% from the quarter before.
Was Outset Medical profitable in the second quarter 2026?
Operating loss was $15.7M (-49.6% of revenue) and net loss $18.0M.
Source: Outset Medical 10-Q on SEC EDGAR.